Roger D Klein, MD, JD, expert with the Regulatory Transparency Project’s FDA and Health Working Group. Former Director of Molecular Oncology at the Cleveland Clinic, former advisor to the FDA, CDC, CMS, and HHS, discusses the origins of COVID and the communication issues that continue to befall our health agencies
You can follow Dr. Klein on twitter @RogerDKlein